These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2098520)

  • 1. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
    Johnston JO; Wright CL; Holbert GW; Benson HD
    J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 10-(2-propynyl)-estr-4-ene-3,17-dione (MDL 18,962)--a mechanism-based irreversible inhibitor of aromatase--in cultured human foreskin fibroblasts.
    Kruter RH; Berkovitz GD; Migeon CJ; Brown TR
    J Steroid Biochem; 1987 Aug; 28(2):139-45. PubMed ID: 3626551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent inhibition of aromatase in trophoblastic tumor cells in tissue culture.
    Johnston JO; Wright CL; Metcalf BW
    J Steroid Biochem; 1984 Jun; 20(6A):1221-6. PubMed ID: 6540337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
    Numazawa M; Mutsumi A; Tachibana M
    Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase.
    Johnston JO; Wright CL; Metcalf BW
    Endocrinology; 1984 Aug; 115(2):776-85. PubMed ID: 6745181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of A-ring steroids.
    Johnston JO; Wright CL; Burkhart JP; Peet NP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
    Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
    Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological characterization of 10-(2-propynyl) estr-4-ene-3, 17-dione (MDL 18,962), an enzyme-activated inhibitor of aromatase.
    Johnston JO
    Steroids; 1987; 50(1-3):105-20. PubMed ID: 2847370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
    J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 2,2-dimethyl-4-hydroxy-4-androstene-3,17-dione as an inhibitor of aromatase.
    Furth PS; Rosenberger J; Marcotte PA; Robinson CH
    J Enzyme Inhib; 1990; 4(2):131-5. PubMed ID: 2098519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human trophoblast xenografts in athymic mice: a model for peripheral aromatization.
    Johnston JO; Wright CL; Shumaker RC
    J Steroid Biochem; 1989 Oct; 33(4A):521-9. PubMed ID: 2811362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Methylene-substituted androgens as novel aromatization inhibitors. Evidence of a requirement for C-3 oxygen in C-19 hydroxylations.
    Miyairi S; Fishman J
    J Biol Chem; 1986 May; 261(15):6772-7. PubMed ID: 3700413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of peripheral aromatization in baboons by an enzyme-activated aromatase inhibitor (MDL 18,962).
    Longcope C; Femino A; Johnston JO
    Endocrinology; 1988 May; 122(5):2007-11. PubMed ID: 3359974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
    Numazawa M; Tachibana M
    Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A photoaffinity inhibitor of aromatase.
    Brueggemeier RW; Snider CE; Kimball JG
    Steroids; 1982 Dec; 40(6):679-89. PubMed ID: 7187716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione.
    Brandt ME; Puett D; Covey DF; Zimniski SJ
    J Steroid Biochem; 1988 Sep; 31(3):317-24. PubMed ID: 3419162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme interactions of 2,10-ethanoandrostene-3,17-dione: aromatase and 17 beta-hydroxysteroid dehydrogenase.
    Greway AT; Mentzer M; Levy MA
    Biochem Int; 1990; 20(3):591-7. PubMed ID: 2161228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione.
    Abul-Hajj YJ; Liu XP; Hedge M
    Steroids; 1995 May; 60(5):423-7. PubMed ID: 7570717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.